The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A phase I dose-escalation trial of TH-302 with nab-paclitaxel and gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.

Anthony J.  Olszanski

Consulting or Advisory Role - Bristol-Myers Squibb; iCeutica; Merck; Millennium; Santaris

Research Funding - EMD Serono (Inst); Incyte (Inst); Millennium (Inst); Novartis (Inst); Teva (Inst)

Andrea  Wang-Gillam

Consulting or Advisory Role - Merrimack

Research Funding - EMD Serono (Inst); Halozyme (Inst); Merrimack (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst)

Eunice Lee  Kwak

Research Funding - Merck

Kamal  Nazzal

No Relationships to Disclose

Fazal  Mehdi

No Relationships to Disclose

Mitesh J.  Borad

No Relationships to Disclose